Daniel I. R. Spencer
Papers
5
Total Citations
212
H-Index
4
About
Daniel I. R. Spencer is a prominent analytical biochemist whose research sits at the intersection of glycomics, biopharmaceuticals, and biomarker discovery. His work has significantly advanced the field of glycoprotein analysis, with a particular focus on developing high-throughput and automated methodologies that make complex glycan characterization faster, more reproducible, and scalable for both research and industry applications. Spencer's most influential contributions include pioneering automated permethylation workflows for MALDI-TOF-MS-based glycosylation analysis, a technique critical for monitoring biopharmaceutical therapeutics throughout their development lifecycle — work that has garnered 78 citations. His 2014 review on high-throughput glycomics technologies (83 citations) has become a key reference for researchers navigating advances in glycoprotein structural studies and glycan biomarker discovery. He has further extended his impact into O-glycosylation analysis and immunoglobulin glycoprofiling, and has contributed to validating robust serum N-glycan profiling methodologies for clinical biomarker studies. With a career dedicated to bridging analytical innovation and biomedical application, Spencer's work has shaped how researchers and biopharma companies approach Quality by Design frameworks and personalized medicine strategies, cementing his reputation as a leading figure in translational glycoscience.
Research Focus
Key Achievements
Top Papers
- 1High-Throughput Analysis and Automation for Glycomics Studies83 citations · 2014
- 2
- 3
- 4
- 5Automation of Immunoglobulin Glycosylation Analysis3 citations · 2021